Safety of factor VIII inhibitor bypass activity (FEIBA<sup>®</sup> ): 10-year compilation of thrombotic adverse events.
- Published in:
- Haemophilia, 2002, v. 8, n. 2, p. 83, doi. 10.1046/j.1365-2516.2002.00532.x
- By:
- Publication type:
- Article
Works matching IS 13518216 AND DT 2002 AND VI 8 AND IP 2
Results: 16
1
2
Modified magnetic resonance imaging score compared with orthopaedic and radiological scores for the evaluation of haemophilic arthropathy.
- Published in:
- Haemophilia, 2002, v. 8, n. 2, p. 98, doi. 10.1046/j.1365-2516.2002.00585.x
- By:
- Publication type:
- Article
3
Genomic interaction in haemophilia: uncharted territory.
- Published in:
- Haemophilia, 2002, v. 8, n. 2, p. 157, doi. 10.1046/j.1365-2516.2002.00586.x
- By:
- Publication type:
- Article
4
Use of recombinant factor IX in subjects with haemophilia B undergoing surgery.
- Published in:
- Haemophilia, 2002, v. 8, n. 2, p. 91, doi. 10.1046/j.1365-2516.2002.00587.x
- By:
- Publication type:
- Article
5
Massive retroperitoneal pseudotumour in a patient with type 3 von Willebrand disease.
- Published in:
- Haemophilia, 2002, v. 8, n. 2, p. 136, doi. 10.1046/j.1365-2516.2002.00588.x
- By:
- Publication type:
- Article
6
Efficacy of desmopressin as surgical prophylaxis in patients with acquired von Willebrand disease undergoing thyroid surgery.
- Published in:
- Haemophilia, 2002, v. 8, n. 2, p. 142, doi. 10.1046/j.1365-2516.2002.00589.x
- By:
- Publication type:
- Article
7
Successful use of recombinant factor VIIa in a patient with inhibitor secondary to severe factor XI deficiency.
- Published in:
- Haemophilia, 2002, v. 8, n. 2, p. 145, doi. 10.1046/j.1365-2516.2002.00590.x
- By:
- Publication type:
- Article
8
Health-related quality-of-life treatments for severe haemophilia: utility measurements using the Standard Gamble technique.
- Published in:
- Haemophilia, 2002, v. 8, n. 2, p. 112, doi. 10.1046/j.1365-2516.2002.00591.x
- By:
- Publication type:
- Article
9
Haemophilia Utilization Group Study: assessment of functional health status in haemophilia.
- Published in:
- Haemophilia, 2002, v. 8, n. 2, p. 121, doi. 10.1046/j.1365-2516.2002.00592.x
- By:
- Publication type:
- Article
10
Long-term follow-up after intertrochanteric varus osteotomy for haemophilic arthropathy of the hip.
- Published in:
- Haemophilia, 2002, v. 8, n. 2, p. 149, doi. 10.1046/j.1365-2516.2002.00593.x
- By:
- Publication type:
- Article
11
Observations from Global Survey 2001: an emerging database for progress.
- Published in:
- Haemophilia, 2002, v. 8, n. 2, p. 153, doi. 10.1046/j.1365-2516.2002.00616.x
- By:
- Publication type:
- Article
12
Factor VIII and transmissible spongiform encephalopathy: the case for safety.
- Published in:
- Haemophilia, 2002, v. 8, n. 2, p. 63, doi. 10.1046/j.1365-2516.2002.00617.x
- By:
- Publication type:
- Article
13
Bone fractures in the haemophilic patient.
- Published in:
- Haemophilia, 2002, v. 8, n. 2, p. 104, doi. 10.1046/j.1365-2516.2002.00628.x
- By:
- Publication type:
- Article
14
Table of Contents.
- Published in:
- 2002
- Publication type:
- Table of Contents
15
A randomized study of alpha-interferon plus ribavirin for 6 months or 12 months for the treatment of chronic hepatitis C in patients with bleeding disorders.
- Published in:
- Haemophilia, 2002, v. 8, n. 2, p. 129, doi. 10.1046/j.1365-2516.2002.00629.x
- By:
- Publication type:
- Article
16
Experience of prophylaxis treatment in children with severe haemophilia.
- Published in:
- Haemophilia, 2002, v. 8, n. 2, p. 76, doi. 10.1046/j.1365-2516.2002.00630.x
- By:
- Publication type:
- Article